Ultragenyx Pharmaceutical Inc (RARE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

60 LEVERONI COURT NOVATO, CA 94949

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

Data as of 2021-09-19 12:45:46 -0400
Market Cap6.666 Billion Shares Outstanding67.836 Million Avg 30-day Volume366.773 Thousand
P/E Ratio-18.9692 Dividend Yield EPS-5.43
Price/Sales18.55 Debt to Equity1.56 EBITDA-323.028 Million
Price to Book Value6.86 Forward PE-0.86 Enterprise Value5.82 Billion
Total Cash845.756 Million Current Debt127.067 Million Gross Profit343.229 Million
BETA1.46571 52-week High/Low179.65 / 76.78 Next Earnings Date2021-10-26 Price to Cash FLow (P/CF) -52.5543
Data provided by IEX Cloud

Are you looking for these stocks instead?

View SEC Filings from RARE instead.

View recent insider trading info

Funds Holding RARE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RARE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

12.3 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

12.3 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PARSCHAUER KARAH HERDMAN EVP AND GENERAL COUNSEL

  • Officer
46,332 2021-09-08 10

BEDROSIAN CAMILLE L EVP AND CHIEF MEDICAL OFFICER

  • Officer
186,050 2021-09-01 7

HARRIS ERIK EVP & CHIEF COMMERCIAL OFFICER

  • Officer
25,333 2021-07-06 6

SANDERS CORAZON (CORSEE) D.

  • Director
0 2021-06-29 2

WELCH DANIEL G

  • Director
18,570 2021-06-24 1

DUNSIRE DEBORAH

  • Director
16,695 2021-06-24 1

EKMAN LARS

  • Director
18,570 2021-06-24 1

NARACHI MICHAEL

  • Director
18,570 2021-06-24 1

FUST MATTHEW K

  • Director
19,820 2021-06-24 1

ALISKI WILLIAM

  • Director
151,780 2021-06-24 3

SULIMAN SHEHNAAZ

  • Director
11,820 2021-06-24 1

KAKKIS EMIL D PRESIDENT & CEO

  • Officer
  • Director
2,854,941 2021-05-06 7

KASSBERG THOMAS RICHARD CBO & EVP

  • Officer
106,818 2021-05-06 3

HUIZENGA THEODORE ALAN SVP, CHIEF ACCOUNTING OFFICER

  • Officer
15,031 2021-05-06 7

HUANG DENNIS KARL EVP & CHIEF TECH OPS OFFICER

  • Officer
40,506 2021-05-06 3

PINION JOHN RICHARD SEE REMARKS

  • Officer
50,122 2021-05-06 4

DIER MARDI CFO & EXECUTIVE VICE PRESIDENT

  • Officer
56,500 2021-03-01 3

SHARP SHALINI EVP, FINANCE

  • Officer
97,812 2020-10-14 1

SIEGALL CLAY B

  • Director
2,550 2020-08-07 0

HOGENHUIS WLADIMIR CHIEF OPERATING OFFICER

  • Officer
18,703 2019-10-04 0

DALLAS JAYSON DONALD ALEXANDER EVP & CHIEF COMMERCIAL OFFICER

  • Officer
23,830 2018-06-01 0

AGARWAL SUNIL CHIEF MEDICAL OFFICER

9,136 2016-08-19 0

FMR LLC

  • SEE REMARK 1.
No longer subject to file 2014-08-01 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • FORMER 10% OWNER (2)(3)(4)(5)FORMER 10% OWNER (2)(3)(4)(5)FORMER 10% OWNER (2)(3)(4)(5)
No longer subject to file 2014-07-14 0

NADAV ERAN

  • Director
0 2014-07-10 0

STEEN MARTEN

  • Director
0 2014-01-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PARSCHAUER KARAH HERDMAN - Officer EVP AND GENERAL COUNSEL

2021-09-09 18:22:25 -0400 2021-09-08 M 7,336 d 17,664 direct

PARSCHAUER KARAH HERDMAN - Officer EVP AND GENERAL COUNSEL

2021-09-09 18:22:25 -0400 2021-09-08 S 7,336 $100.65 d 28,668 direct -1.1997 -3.3632 0.0 1 -6.4313 3

PARSCHAUER KARAH HERDMAN - Officer EVP AND GENERAL COUNSEL

2021-09-09 18:22:25 -0400 2021-09-08 M 7,336 $54.50 a 36,004 direct -1.1997 -3.3632 0.0 1 -6.4313 3

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-09-02 18:11:04 -0400 2021-09-02 M 2,500 d 53,000 direct

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-09-02 18:11:04 -0400 2021-09-02 M 2,500 $55.00 a 41,275 direct -0.4102 -1.8848 0.0 1 -1.8848 6

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-09-02 18:11:04 -0400 2021-09-02 S 2,500 $100.18 d 38,775 direct -0.4102 -1.8848 0.0 1 -1.8848 6

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-09-02 18:11:04 -0400 2021-09-01 M 2,500 $55.00 a 41,275 direct yes -0.4102 -1.8848 0.0 1 -1.8848 6

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-09-02 18:11:04 -0400 2021-09-01 M 2,500 d 55,500 direct

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-09-02 18:11:04 -0400 2021-09-01 S 2,500 $100.03 d 38,775 direct -0.4102 -1.8848 0.0 1 -1.8848 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 22:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 21:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 21:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 20:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 20:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 19:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 19:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 18:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 18:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 17:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 17:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 16:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 16:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 15:45:04 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 15:15:04 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 14:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 14:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 13:45:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 13:15:03 UTC -0.18 0.25 1500000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-09-21 12:45:03 UTC -0.18 0.25 1500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund RARE -1795.0 shares, $-76664.45 2019-12-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund RARE -36.0 shares, $-2958.84 2020-09-30 N-PORT
FundVantage Trust- Gotham Defensive Long Fund RARE -94.0 shares, $-4176.42 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund RARE -36.0 shares, $-1599.48 2020-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund RARE -1228.0 shares, $-139820.08 2021-03-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund RARE -694.0 shares, $-66172.9 2021-06-30 N-PORT

Elevate your investments